GBP2 inhibits pathological angiogenesis in the retina via the AKT/mTOR/VEGFA axis
Microvascular Research · 2024
DOI: 10.1016/j.mvr.2024.104689 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microvascular Research, 2024. Verfasst von Xiaoxiang Xu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy, Anhui Medical University, Hefei, Anhui 230032, China. Hauptthemen laut MEDLINE: Disease Models, Animal, GTP-Binding Proteins, Mice, Inbred C57BL, Proto-Oncogene Proteins c-akt. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Pathological retinal angiogenesis is not only the hallmark of retinopathies, but also a major cause of blindness. Guanylate binding protein 2 (GBP2) has been reported to be associated with retinal diseases such as diabetic retinopathy and hypoxic retinopathy. However, GBP2-mediated pathological retinal angiogenesis remains largely unknown. The present study aimed to investigate the role of GBP2 in pathological retinal angiogenesis and its underlying molecular mechanism. In this study, we established oxygen-induced retinopathy (OIR) mice model for in vivo study and hypoxia-induced angiogenesis in ARPE-19 cells for in vitro study. We demonstrated that GBP2 expression was markedly downregulated in the retina of mice with OIR and ARPE-19 cells treated with hypoxia, which was associated with pathological retinal angiogenesis. The regulatory mechanism of GBP2 in ARPE-19 cells was studied by GBP2 silencing and overexpression. The regulatory mechanism of GBP2 in the retina was investigated by overexpressing GBP2 in the retina of OIR mice. Mechanistically, GBP2 downregulated the expression and secretion of vascular endothelial growth factor (VEGFA) in ARPE-19 cells and retina of OIR mice. Interestingly, overexpression of GBP2 significantly inhibited neovascularization in OIR mice, conditioned medium of GBP2 overexpressing ARPE-19 cells inhibited angiogenesis in human umbilical vein endothelial cells (HUVECs). Furthermore, we confirmed that GBP2 downregulated VEGFA expression and angiogenesis by inhibiting the AKT/mTOR signaling pathway. Taken together, we concluded that GBP2 inhibited pathological retinal angiogenesis via the AKT/mTOR/VEGFA axis, thereby suggesting that GBP2 may be a therapeutic target for pathological retinal angiogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anatomy, Anhui Medical University, Hefei, Anhui 230032, China.
- Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230012, China; Anhui Public Health Clinical Center, Hefei, Anhui 230012, China.
- College and Hospital of Stomatology, Key Lab. of Oral Diseases Research of Anhui Province, Anhui Medical University, Hefei, Anhui 230032, China.
- Hefei Huaxia Mingren Eye Hospital, Hefei, Anhui 230032, China.
- Department of Anatomy, Anhui Medical University, Hefei, Anhui 230032, China. Electronic address: 1292936941@qq.com.
- Department of Anatomy, Anhui Medical University, Hefei, Anhui 230032, China; College and Hospital of Stomatology, Key Lab. of Oral Diseases Research of Anhui Province, Anhui Medical University, Hefei, Anhui 230032, Chin…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Xu, X., Ding, X., Wang, Z., Ye, S., Xu, J., Liang, Z., Luo, R., Xu, J., Li, X., & Ren, Z. (2024). GBP2 inhibits pathological angiogenesis in the retina via the AKT/mTOR/VEGFA axis. Microvascular Research. https://doi.org/10.1016/j.mvr.2024.104689
Vancouver
Xu X, Ding X, Wang Z, Ye S, Xu J, Liang Z, et al. GBP2 inhibits pathological angiogenesis in the retina via the AKT/mTOR/VEGFA axis. Microvascular Research. 2024. doi:10.1016/j.mvr.2024.104689
BibTeX
@article{Xu2024,
author = {Xu, Xiaoxiang and Ding, Xihui and Wang, Zizhuo and Ye, Shujiang and Xu, Jianguang and Liang, Zugang and Luo, Renfei and Xu, Jinyong and Li, Xiaohui and Ren, Zhenhua},
title = {GBP2 inhibits pathological angiogenesis in the retina via the AKT/mTOR/VEGFA axis},
journal = {Microvascular Research},
year = {2024},
doi = {10.1016/j.mvr.2024.104689}
}
EUVIMED